Proniras Corp
- UEI
- GJ4UUPRHHNF9
- CAGE
- 7VNX1
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- proniras.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Proniras corporation | Office of the Assistant Secretary for Preparedness and Response | $3,668,396 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Amygdala Neurosciences, Inc. | Palo Alto, CA | — |
| Epivario Inc. | Philadelphia, PA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Afasci, Inc. | Burlingame, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Camino Pharma LLC | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Workit Health Inc. | Ann Arbor, MI | 513210 Software Publishers |
About the company
Proniras Corporation is a specialty pharmaceutical company focused on developing therapies for those fighting addiction. Proniras has received multiple federal grant subawards from the Trustees of Indiana University to support the development of its lead compound, tezampanel, for the treatment of opioid addiction.
The federal subawards to Proniras have supported specific milestones in the preclinical and clinical development process for tezampanel. This includes toxicology studies, manufacturing process development and stability testing, meetings with the FDA, and early phase clinical trials. The subawards fall under federal grant programs related to substance abuse and addiction research. Proniras serves as a subawardee carrying out discrete scopes of work to achieve development milestones for the tezampanel program. The prime grantee on these awards is the Trustees of Indiana University. Through this partnership, Proniras leverages federal funding to advance its proprietary addiction therapy through key preclinical and early clinical activities.
Quick answers
Is Proniras Corp registered in SAM.gov?
Proniras Corp's SAM.gov registration expired on November 19, 2024.
What is Proniras Corp's most recent federal award?
Proniras Corp's most recent federal contract award is Proniras corporation (75A50118C00008), from Office of the Assistant Secretary for Preparedness and Response, on April 25, 2018.
On GovTribe
See Proniras Corp's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors